Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study
| dc.contributor.author | Aldred, J | |
| dc.contributor.author | Freire-Alvarez, E | |
| dc.contributor.author | Amelin, AV | |
| dc.contributor.author | Antonini, A | |
| dc.contributor.author | Bergmans, B | |
| dc.contributor.author | Bergquist, F | |
| dc.contributor.author | Bouchard, M | |
| dc.contributor.author | Budur, K | |
| dc.contributor.author | Carroll, C | |
| dc.contributor.author | Chaudhuri, KR | |
| dc.contributor.author | Criswell, SR | |
| dc.contributor.author | Danielsen, EH | |
| dc.contributor.author | Gandor, F | |
| dc.contributor.author | Jia, J | |
| dc.contributor.author | Kimber, TE | |
| dc.contributor.author | Mochizuki, H | |
| dc.contributor.author | Robieson, WZ | |
| dc.contributor.author | Spiegel, AM | |
| dc.contributor.author | Standaert, DG | |
| dc.contributor.author | Talapala, S | |
| dc.contributor.author | Facheris, MF | |
| dc.contributor.author | Fung, VSC | |
| dc.date.accessioned | 2023-12-04T22:57:46Z | |
| dc.date.available | 2023-12-04T22:57:46Z | |
| dc.date.issued | 2023-10-10 | |
| dc.identifier.issn | 2193-8253 | |
| dc.identifier.issn | 2193-6536 | |
| dc.identifier.uri | https://pearl.plymouth.ac.uk/handle/10026.1/21770 | |
| dc.description.abstract |
Correction: Neurol Ther https://doi.org/10.1007/s40120-023-00533-1 | |
| dc.format.extent | 1959-1960 | |
| dc.format.medium | ||
| dc.language | en | |
| dc.publisher | Springer Science and Business Media LLC | |
| dc.subject | 32 Biomedical and Clinical Sciences | |
| dc.subject | 3202 Clinical Sciences | |
| dc.title | Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study | |
| dc.type | other | |
| plymouth.author-url | https://www.ncbi.nlm.nih.gov/pubmed/37817017 | |
| plymouth.confidential | false | |
| plymouth.issue | 6 | |
| plymouth.volume | 12 | |
| plymouth.publisher-url | http://dx.doi.org/10.1007/s40120-023-00554-w | |
| plymouth.publication-status | Published | |
| plymouth.journal | Neurology and Therapy | |
| dc.identifier.doi | 10.1007/s40120-023-00554-w | |
| plymouth.organisational-group | |Plymouth | |
| plymouth.organisational-group | |Plymouth|Research Groups | |
| plymouth.organisational-group | |Plymouth|Faculty of Health | |
| plymouth.organisational-group | |Plymouth|Research Groups|Institute of Translational and Stratified Medicine (ITSMED) | |
| plymouth.organisational-group | |Plymouth|Research Groups|Institute of Translational and Stratified Medicine (ITSMED)|CCT&PS | |
| plymouth.organisational-group | |Plymouth|REF 2021 Researchers by UoA | |
| plymouth.organisational-group | |Plymouth|Users by role | |
| plymouth.organisational-group | |Plymouth|Users by role|Academics | |
| plymouth.organisational-group | |Plymouth|REF 2021 Researchers by UoA|UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy | |
| plymouth.organisational-group | |Plymouth|Faculty of Health|Peninsula Medical School | |
| plymouth.organisational-group | |Plymouth|Research Groups|FoH - Community and Primary Care | |
| plymouth.organisational-group | |Plymouth|Research Groups|FoH - Applied Parkinson's Research | |
| plymouth.organisational-group | |Plymouth|Research Groups|Plymouth Institute of Health and Care Research (PIHR) | |
| plymouth.organisational-group | |Plymouth|REF 2028 Researchers by UoA | |
| plymouth.organisational-group | |Plymouth|REF 2028 Researchers by UoA|UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy | |
| dc.publisher.place | New Zealand | |
| dc.date.updated | 2023-12-04T22:57:41Z | |
| dc.rights.embargodate | 2024-3-14 | |
| dc.identifier.eissn | 2193-6536 | |
| dc.rights.embargoperiod | ||
| rioxxterms.versionofrecord | 10.1007/s40120-023-00554-w |
